Eastman Chemical (EMN) nosedived 24.41% after missing earnings and slashing forecasts. But is the panic warranted—or is Wall Street ignoring a potential rebound?In this episode of Am I Catching a Falling Knife?, Dave unpacks EMN’s business breakdown, the macro threats from trade policy, and a stormy balance sheet with $5.13B in debt and negative cash flow.Get the full analysis—from earnings stumbles to segment-by-segment damage control.📌 Subscribe for deep-dive market dissections with just enough satire to stay sane.⚠️ This isn’t financial advice—just finance entertainment, Dave-style.#stockanalysis #marketdip #stockcrash